|
|
|
|
| LEADER |
01246caa a2200349 ir4500 |
| 001 |
NSK01000311812 |
| 003 |
HR-ZaNSK |
| 005 |
20070920024257.0 |
| 008 |
020408s2001 ci ||| ||eng |
| 015 |
|
|
|a HP01-2376
|2 HR
|
| 035 |
|
|
|9 (HR-ZaNSK)312142
|
| 035 |
|
|
|9 (HR-ZaNSK)420408097
|
| 035 |
|
|
|a (HR-ZaNSK)000311812
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 041 |
0 |
|
|a eng
|b hrv
|
| 080 |
|
|
|a 616.12-008.331.1:615.01
|
| 080 |
|
|
|a 615.01:616.12-008.331.1
|
| 100 |
1 |
|
|a Agrawal, Vijay K.
|
| 245 |
1 |
0 |
|a QSAR studies on antihypertensive activity of 4-(diarylmethyl)-N-substituted piperidines /
|c Vijay K. Agrawal, Rajneesh C. Srivastava, Padmakar V. Khadikar.
|
| 246 |
1 |
3 |
|a Quantitative structure-activity relationship
|
| 300 |
|
|
|b Ilustr.
|
| 504 |
|
|
|a Bibliografija: 16 jed
|
| 504 |
|
|
|a Sažetak
|
| 650 |
|
7 |
|a Hipertenzija
|x Farmakološka istraživanja
|2 nskps
|
| 650 |
|
7 |
|a Lijekovi
|x QSAR modeliranje
|2 nskps
|
| 700 |
1 |
|
|a Srivastava, Rajneesh C.
|
| 700 |
1 |
|
|a Khadikar, Padmakar V.
|
| 773 |
0 |
|
|t Acta pharmaceutica (Zagreb)
|x 1330-0075
|g 51 (2001), 2 ; str. 117-130
|w nsk.(HR-ZaNSK)000054908
|
| 932 |
|
|
|a da
|
| 981 |
|
|
|p CRO
|z B4/01
|
| 998 |
|
|
|a iteo0204
|a boki0207
|c vebo0401
|c rjkp0402
|
| 886 |
0 |
|
|2 unimarc
|b 01019naa2 2200277 450
|